Gossamer Bio, Inc.
GOSS
$1.45
$0.1511.54%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/15/2025
-
TipRanks Financial Blog
3/14/2025
-
MarketBeat
3/14/2025
-
MarketBeat
3/14/2025
-
Ticker Report
3/13/2025
-
GuruFocus
3/13/2025
-
GuruFocus
3/13/2025
-
Zacks Investment Research
3/13/2025
-
SeekingAlpha.com: All News
3/13/2025
-
The Fly
3/13/2025
-
The Fly
3/13/2025
-
Business Wire
3/7/2025
-
GuruFocus
3/7/2025
-
Business Wire
2/25/2025
-
MarketBeat
2/14/2025
-
SeekingAlpha
2/14/2025
-
Seeking Alpha - Long Ideas
2/7/2025
-
GuruFocus
2/7/2025
-
Business Wire
2/6/2025
-
GuruFocus
2/3/2025
-
GuruFocus
2/3/2025
-
Business Wire
2/1/2025
-
MarketBeat
1/31/2025
-
MarketBeat
1/31/2025
-
GuruFocus
1/30/2025
-
Simply Wall St
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 7, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 684 1300
Address
3013 Science Park Road
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United...
more
